Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print November 19, 2008, doi:10.1212/01.wnl.0000333665.01888.33)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
01.wnl.0000333665.01888.33v1
72/6/490    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bachinski, L. L.
Right arrow Articles by Krahe, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bachinski, L. L.
Right arrow Articles by Krahe, R.
Related Collections
Right arrow All Neuromuscular Disease
Right arrow Muscle disease
Right arrow Trinucleotide repeat diseases
Right arrowRelated Article
NEUROLOGY 2009;72:490-497
© 2009 American Academy of Neurology

Premutation allele pool in myotonic dystrophy type 2

L. L. Bachinski, PhD, T. Czernuszewicz, BS, L. S. Ramagli, PhD, T. Suominen, MS, M. D. Shriver, PhD, B. Udd, MD, PhD, M. J. Siciliano, PhD and R. Krahe, PhD

From the Departments of Cancer Genetics (L.L.B., T.C., R.K.) and Molecular Genetics (L.S.R., M.J.S.), University of Texas M.D. Anderson Cancer Center, Houston, TX; Neurogenetics Program (T.S.), University of Tampere, Finland; Department of Neurology (B.U.), Tampere University Hospital, Finland; and Department of Anthropology (M.D.S.), Pennsylvania State University, University Park, PA.

Address correspondence and reprint requests to Dr. Ralf Krahe, Department of Cancer Genetics, Unit 1010, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030-4009 rkrahe{at}mdanderson.org

Background: The myotonic dystrophies (DM1, DM2) are the most common adult muscle diseases and are characterized by multisystem involvement. DM1 has been described in diverse populations, whereas DM2 seems to occur primarily in European Caucasians. Both are caused by the expression of expanded microsatellite repeats. In DM1, there is a reservoir of premutation alleles; however, there have been no reported premutation alleles for DM2. The (CCTG)DM2 expansion is part of a complex polymorphic repeat tract of the form (TG)n(TCTG)n(CCTG)n(NCTG)n(CCTG)n. Expansions are as large as 40 kb, with the expanded (CCTG)n motif uninterrupted. Reported normal alleles have up to (CCTG)26 with one or more interruptions.

Methods: To identify and characterize potential DM2 premutation alleles, we cloned and sequenced 43 alleles from 23 individuals. Uninterrupted alleles were identified, and their instability was confirmed by small-pool PCR. We determined the genotype of a nearby single nucleotide polymorphism (rs1871922) known to be in linkage disequilibrium with the DM2 mutation.

Results: We identified three classes of large non-DM2 repeat alleles: 1) up to (CCTG)24 with two interruptions, 2) up to (CCTG)32 with up to four interruptions, and 3) uninterrupted (CCTG)22–33. Large non-DM2 alleles were more common in African Americans than in European Caucasians. Uninterrupted alleles were significantly more unstable than interrupted alleles (p = 10–4 to 10–7). Genotypes at rs1871922 were consistent with the hypothesis that all large alleles occur on the same haplotype as the DM2 expansion.

Conclusions: We conclude that unstable uninterrupted (CCTG)22-33 alleles represent a premutation allele pool for DM2 full mutations.

Abbreviations: AfrAm = African American; DM = myotonic dystrophy; EurCauc = European Caucasian; FISH = fluorescent in situ hybridization; MIM = Mendelian Inheritance in Man; NA = not available; SNP = single nucleotide polymorphism; SP-PCR = small-pool PCR.


Supplemental data at www.neurology.org

Editorial, page 484

e-Pub ahead of print on November 19, 2008, at www.neurology.org.

R.K. was supported in part by NIH grant AR48171 and MDA. B.U. was supported by Medicinska understödsföreningen Liv och Hälsa r.f., the Tampere University Hospital Research Funds, and the Folkhälsan Institute of Genetics.

Disclosure: The authors report no disclosures.

Received April 21, 2008. Accepted in final form July 22, 2008.


Related Article

How much expansion to be diseased?: Toward repeat size and myotonic dystrophy type 2
Benedikt Schoser and Tetsuo Ashizawa
Neurology 2009 72: 484-485. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. F. Edwards, M. Sirito, R. Krahe, and R. R. Sinden
A Z-DNA sequence reduces slipped-strand structure formation in the myotonic dystrophy type 2 (CCTG){middle dot}(CAGG) repeat
PNAS, March 3, 2009; 106(9): 3270 - 3275.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. Schoser and T. Ashizawa
How much expansion to be diseased?: Toward repeat size and myotonic dystrophy type 2
Neurology, February 10, 2009; 72(6): 484 - 485.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by AAN Enterprises, Inc.